<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Guillo L</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Women with endometriosis have a higher risk of developing inflammatory bowel diseases (IBDs). This study aimed to better understanding the impact of endometriosis on the course of IBD.&lt;h4>Methods&lt;/h4>We conducted a retrospective cohort study in 18 French and Belgian IBD centers between June 2022 and March 2023. Any patient with both conditions was eligible for inclusion. They were randomly matched to 1 or 2 patients with IBD without endometriosis. The impact on IBD progression was assessed using a composite severity criterion including intestinal damage or need for bowel surgery.&lt;h4>Results&lt;/h4>Overall, 207 patients with both conditions (149 Crohn's disease [CD]; 58 ulcerative colitis [UC]) were matched to 409 patients with IBD alone. The median follow-up duration for </pubmed_abstract><journal>Clinical and translational gastroenterology</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12922932</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Impact of Endometriosis on the Progression of Inflammatory Bowel Diseases: A Multicenter Retrospective Study.</pubmed_title><pmcid>PMC12922932</pmcid><pubmed_authors>Nancey S</pubmed_authors><pubmed_authors>Labreuche J</pubmed_authors><pubmed_authors>Abitbol V</pubmed_authors><pubmed_authors>Bourrier A</pubmed_authors><pubmed_authors>Vidon M</pubmed_authors><pubmed_authors>Serrero M</pubmed_authors><pubmed_authors>Le Cosquer G</pubmed_authors><pubmed_authors>Rubod C</pubmed_authors><pubmed_authors>Uzzan M</pubmed_authors><pubmed_authors>Caillo L</pubmed_authors><pubmed_authors>Meheut L</pubmed_authors><pubmed_authors>Richard N</pubmed_authors><pubmed_authors>Reenaers C</pubmed_authors><pubmed_authors>Atanasiu C</pubmed_authors><pubmed_authors>El Oumami O</pubmed_authors><pubmed_authors>Buisson A</pubmed_authors><pubmed_authors>Nuzzo A</pubmed_authors><pubmed_authors>Caron B</pubmed_authors><pubmed_authors>Benezech A</pubmed_authors><pubmed_authors>Wils P</pubmed_authors><pubmed_authors>Le Berre C</pubmed_authors><pubmed_authors>Guillo L</pubmed_authors><pubmed_authors>Seksik P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Impact of Endometriosis on the Progression of Inflammatory Bowel Diseases: A Multicenter Retrospective Study.</name><description>&lt;h4>Introduction&lt;/h4>Women with endometriosis have a higher risk of developing inflammatory bowel diseases (IBDs). This study aimed to better understanding the impact of endometriosis on the course of IBD.&lt;h4>Methods&lt;/h4>We conducted a retrospective cohort study in 18 French and Belgian IBD centers between June 2022 and March 2023. Any patient with both conditions was eligible for inclusion. They were randomly matched to 1 or 2 patients with IBD without endometriosis. The impact on IBD progression was assessed using a composite severity criterion including intestinal damage or need for bowel surgery.&lt;h4>Results&lt;/h4>Overall, 207 patients with both conditions (149 Crohn's disease [CD]; 58 ulcerative colitis [UC]) were matched to 409 patients with IBD alone. The median follow-up duration for </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-07-16T12:56:53.151Z</modification><creation>2026-07-09T10:56:31.553Z</creation></dates><accession>S-EPMC12922932</accession><cross_references><pubmed>41359916</pubmed><doi>10.14309/ctg.0000000000000954</doi></cross_references></HashMap>